Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Sanofi's middling future, Amgen's $10B shopping list, and a novel pharma lawsuit
Fierce editors discuss Sanofi's uninspiring forecast, Amgen's return to high-dollar dealmaking and a lawsuit that accuses a drug company of deliberately being bad at making drugs.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
